Inadequate growth hormone suppression following an octreotide test dose predicts the need for adjuvant therapy to achieve 'safe' growth hormone levels.
Lindsay
John R
JR
Atkinson
A Brew
AB
D000172:Acromegaly / Q000097:blood*; D017024:Chemotherapy, Adjuvant; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D015282:Octreotide; D018579:Patient Selection
D013006:Growth Hormone; D015282:Octreotide